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Abstract
Objectives The aim of our study was to estimate the
health-related and economic burden of suicide in Poland in
2012 and to demonstrate the effects of using different
assumptions on the disease burden estimation.
Methods Years of life lost (YLL) were calculated by
multiplying the number of deaths by the remaining life
expectancy. Local expected YLL (LEYLL) and standard
expected YLL (SEYLL) were computed using Polish life
expectancy tables and WHO standards, respectively. In the
base case analysis LEYLL and SEYLL were computed
with 3.5 and 0% discount rates, respectively, and no age-
weighting. Premature mortality costs were calculated using
a human capital approach, with discounting at 5%, and are
reported in Polish zloty (PLN) (1 euro = 4.3 PLN). The
impact of applying different assumptions on base-case
estimates was tested in sensitivity analyses.
Results The total LEYLLs and SEYLLs due to suicide
were 109,338 and 279,425, respectively, with 88%
attributable to male deaths. The cost of male premature
mortality (2,808,854,532 PLN) was substantially higher
than for females (177,852,804 PLN). Discounting and age-
weighting have a large effect on the base case estimates of
LEYLLs. The greatest impact on the estimates of suicide-
related premature mortality costs was due to the value of
the discount rate.
Conclusions Our findings provide quantitative evidence on
the burden of suicide. In our opinion each of the demon-
strated methods brings something valuable to the evalua-
tion of the impact of suicide on a given population, but
LEYLLs and premature mortality costs estimated accord-
ing to national guidelines have the potential to be useful for
local public health policymakers.
Keywords Years of expected life lost  Premature
mortality costs  Suicide  Poland  Burden of disease
JEL Classification I18
Introduction
Suicide accounted for 1.4 and 1.48% of all deaths worldwide
in 2012 and 2015, respectively [1, 2], making it the 14th
leading cause of death [2]. In Poland it was the leading cause
of death among people aged 15–39 [3]. The World Health
Organisation (WHO) recognizes suicide as a public health
priority, calls for action to address this problem and
encourages countries to develop or strengthen comprehen-
sive suicide prevention strategies [1]. In debates on research
funding and public health issues it is necessary to quantify
the burden of suicide, both health-related and economic. A
variety of different metrics is available to estimate the health-
related impact any given event or disease has on society: e.g.,
number of deaths, mortality rate (crude or standardized), and
years of life lost (YLL). Traditional mortality statistics
(number of deaths, mortality rate) deny the fact that death at a
young age is, compared with death at an advanced age,
generally considered to be a greater loss not only to an
individual, but to the society as well. YLL, however, weighs
deaths at a young age more heavily than those at a more
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advanced age [4–6]. Besides the obvious advantages of using
the YLL, one may encounter difficult issues, e.g., theoretical
and philosophical problems of discounting the value of life
lived in the far future, age-weighting and the practical
problem of using life tables (either standard reference or
country-specific life tables). Although the GBD (global
burden of disease) Mortality and Causes of Death Collabo-
rators, a large international consortium of researchers led by
the Institute for Health Metrics and Evaluation (IHME)
attempted to standardize YLL with respect to standard model
life tables [2, 7, 8], authors of recently published studies still
use alternative standards [9–13]. Manipulations of YLL—
discounting, age-weighting, age-standardizing—are also
variously applied [9–13]. This methodological diversity
results in the fact that YLL is not routinely used by policy-
makers for measuring and monitoring the impact of local
efforts to reduce premature mortality in a given population.
From the economic point of view, every suicide-related
death of someone of working age represents a financial loss
to society. One of the ways to measure the economic impact
of suicide is to estimate the cost of lost productivity due to
suicide-related premature mortality. The aim of the study is
to apply a consistent methodology for population-based data
to estimate the health-related and economic impact of sui-
cide in Poland. We have examined the effect of replacing
standard model life tables with Polish life-expectancy values
to illustrate how each method of calculating YLL provides a
different value of the burden suicide has on that society. We
have used different scenarios in our YLL calculations to
demonstrate the effects of time-discounting and age-
weighting on the disease burden estimation. To allow the
interpretation of results, we referred suicide-related esti-
mates to the overall mortality burden of all causes of death in
Poland in 2012.
Methods
Absolute numbers of suicide-related deaths and all causes of
death by sex and 5-year age groups (0–4, 5–9, 10–14, (…),
75–79, 80–84,[85) were extracted from the Polish Central
Statistics Office database. We have focused on the most recent
complete data, which was for the year 2012. YLL was cal-
culated as country-specific (local) expected years of life lost
(LEYLL) and standard expected years of life lost (SEYLL).
Country-specific life expectancy values for each 5-year age
group for males and females living in Poland was derived from
life tables for 2012, with a life expectancy of 80.98 years at
birth in women and 77.71 years in men [14]. Each LEYLL
value was calculated by multiplying the mortality values by
the remaining life expectancy values for each age category
and than summed to illustrate the overall LEYLL. No cutoff
for age was used for the calculation, age at death at each
interval was a midpoint of the range, e.g., each death in the
25–29 age group was considered to be 27.5. In the base case
analysis LEYLL was computed with a time discount rate at
3.5% and no age-weighting, as recommended by the Polish
health technology assessment guidelines [15]. Mean LEYLL
was measured by dividing the overall LEYLL by the number
of deaths. SEYLL was determined by the average life
expectancy at the age of death, using the normative sur-
vivorship derived from a model life table. In the base case
calculation we have used the most recent WHO Global Health
Estimates (WHO GHE) standard life table, which is based on
the frontier national life expectancy projected for the year
2050 by the World Population Prospects 2012 and gives a life
expectancy of 91.9 years at birth for both sexes [16]. The
SEYLL was calculated with a time discount rate at 0% and no
age-weighting, as was recommended by GBD and adopted by
WHO [2, 7, 16].
Costs of premature mortality were estimated using the
human capital approach, which measures lost productivity
with regard to the forgone earnings [17]. For each death over a
working lifetime ([15 years and\ the retirement age, which
in Poland is 60 years for women and 65 for men), years of
potential productive life lost (YPPLL) were calculated and
then valued using sex-specific annual wages from the age of
death until the retirement age. Costs were adjusted for
unemployment and labor force participation rates according to
labor force characteristics in 2012 [18], and discounted at 5%
per annum [15]. Based on the analysis of economic activity
rate by sex in the years 2010–2013 [18], it was assumed that
the economic activity rate for males and females will increase
annually by 1.3 and 0.5%, respectively. Future wage growth
was estimated at 3.4% based on average country-specific GDP
growth from 2000 to 2012. Cost estimates were subsequently
summed over deaths in each 5-year age group and across age
groups to provide total cost of lost productivity due to suicide-
related premature mortality separately for female and male
populations and for both sexes combined. In addition, pre-
mature mortality costs were expressed per single suicide-re-
lated death and per 1000 persons. Costs were expressed in
Polish zloty (PLN) (1 euro = 4.3 PLN in 2016).
Deterministic sensitivity analysis was performed to
assess the impact of changes in key parameters on base-
case estimates of LEYLL, SEYLL and premature mortality
costs. Given that the original GBD 1990 study and subse-
quent WHO updates have applied discounting and age-
weighting to compute YLL, a 3% discount rate and stan-
dard age-weights rate, which gives less weight to years of
healthy life lost at young ages and older ages, were used in
our calculation of LEYLL [19, 20]. In addition, a 0%
discount rate was applied in the LEYLL calculation to
account for more recent WHO and GBD recommendations
[2, 7, 16] and Polish health technology assessment guide-
lines for sensitivity analyses [15].
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In the sensitivity analysis, we calculated SEYLL by
applying the reference life tables used previously in the
GBD studies: (1) West Level-26 with a life expectancy of
80 years at birth for males and 82.5 years for females, age-
weighted and discounted, (2) West Level-26 with a life
expectancy of 80 years at birth for males and 82.5 years for
females, not age-weighted nor discounted, and (3) GBD
2010 with a life expectancy of 86 years at birth for both
males and females, not age-weighted nor discounted [21].
Additionally, we calculated SEYLL applying the up-to-date
reference life tables proposed by IHME and recently used in
GBD 2015, with a normative standard life expectancy at
birth of 86.59 years, not age-weighted nor discounted [2].
For premature mortality cost, different discount rates (0
and 3.5%) were tested [15]. To take into account the
uncertainty over future growth in the Polish economy, 0%
wage growth and 0% economic activity growth were
applied. The estimates of unemployment rates from 2015
were used to reflect more up-to-date changes in the labor
market [22]. Moreover, to account for the change in the
official retirement age to be implemented in Poland in the
near future, the effect of extending the retirement age to 68
for both males and females was explored.
Results
Base case analysis
Number of deaths, LEYLL and SEYLL overall and by sex
A total of 6365 suicides were reported in Poland in 2012,
87% of which were among males. The absolute number of
deaths in each 5-year age category is presented in Fig. 1.
The highest mortality for both sexes was observed among
people aged 50–64 (2035 males and 319 females); the
average age at death was 48 for males and 54 for females.
For comparison, the average age of all-cause mortality was
68.7 for males and 77 for females.
The total LEYLL amounted to 109,338 and was sub-
stantially higher among males than among females (96,388
vs 13,950) (Table 1). Similarly, LEYLL per 1000 persons
was 7 times higher among males, compared to females.
This disparity was caused by a notable difference in the
mortality between sexes: the male mortality in each 5-year
age category was many times greater than that of females
(Fig. 1). However, because of the higher life expectancies
for women, the mean LEYLL was similar for females and
males: 17.22 and 17.17, respectively. The total SEYLL
attributable to suicide amounted to 279,425, 89% of which
was among males. Both mean SEYLL and SEYLL per
1000 persons was higher in males (45 and 13.3, respec-
tively) than in females (39 and 1.6, respectively). A com-
parison of the SEYLL and LEYLL age distribution (Fig. 2)
revealed that the effect of using loss function correspond-
ing to longer life expectancies is more pronounced in the
more advanced age groups. The strongest impact of pro-
longed life-expectancy was identified for women aged 80
and older and for men aged 75 and older, with SEYLL
being 4 times higher than LEYLL.
The LEYLL and SEYLL due to all-cause mortality for both
sexes in Poland were 3,817,452 and 8,457,390, respectively.
When these values were taken as point of reference, the loss of
life years due to suicide accounted for 3% of all-cause mor-
tality-related LEYLL and 3% of all-cause mortality-related
SEYLL. Both mean suicide-related LEYLL and SEYLL
exceeded mean all-cause mortality-related LEYLL and
SEYLL, and the excess was greater for females than males
(Fig. 3).
Fig. 1 Absolute numbers of suicide-related deaths in Poland in 2012
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Table 1 Sensitivity analyses for LEYLL according to different assumptions for the discount rate and age-weighting

































95,388 17.2 5.1 13,950 17.2 0.7 109,338 17.2 2.9
Discount rate (BC: 3.5%)
3% 101,841 7% 18.3 5.5 14,936 7% 18.4 0.8 116,777 7% 18.4 3.0
0% 160,965 69% 29 8.6 24,335 74% 30 1.2 185,300 41% 29.1 4.8
Age weights (BC: no age weights)
Age weights 122,145 28% 21.99 6.5 16,271 17% 20.09 0.8 138,416 27% 21.75 3.59





152,404 59% 27.44 8.2 20,370 46% 25.15 1.0 172,774 58% 27.4 4.48
Fig. 2 a Comparison of the
male SEYLL and LEYLL age
distribution. b Comparison of
the female SEYLL and LEYLL
age distribution
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Premature mortality costs overall and by sex
In the base case analysis, the total cost of lost productivity due
to suicide-related premature mortality was 2,986,707,338
PLN, 94% of which was among males (2,808,854,532 PLN).
The male cost of lost productivity per premature suicide death
exceeded the female cost by 130% (505,644 PLN vs 219,571
PLN). The cost per 1000 persons was 150,614 PLN and 11.04
PLN for males and females, respectively.
The all-cause premature mortality cost was
30,991,739,990 PLN (26,786,245,030 PLN for males and
4,205,494,960 PLN for females), which represents 804,285
PLN per 1000 persons (1,436,311 per 1000 males and
211,502 PLN per 1000 females). Mean cost of lost pro-
ductivity was 80,542 PLN (132,543 PLN per dead male
and 23,013 per dead female). In both sexes combined and
among males, suicide contributed to 10% of overall pre-
mature mortality costs, while female suicide-related pre-
mature mortality cost represented 4% of the overall cost.
For both males and females, the cost of premature mor-
tality per suicide-related death exceeded that of all causes
of death. The excess was more pronounced in the female
population (219,571 PLN vs 23,013) than in the male
population (505,644 PLN vs 132,543 PLN).
Sensitivity analysis
Discounting and age-weighting have a large effect on the
base case estimates of LEYLL. With a 3% discount rate the
total and sex specific LEYLL increases by 7%, with 0%
discount rate LEYLL is in comparison to base case by 41%
higher for both sexes combined and by 69% and 74%
higher for males and females, respectively (Table 1).
Applying age weights had greater impact on LEYLL in
males (increase by 28%) than in females (increase by
17%). In the 0% discount rate and age-weights scenario,
LEYLL was 59% higher in males, 46% higher in females
and 58% higher in both sexes combined. By applying the
loss function which corresponds to longest life expectan-
cies, SEYLL resulted in an approximately 2.5 times bigger
of the total and mean value in comparison to the West
Level-26 with age-weighting and discounting (Table 2).
Table 3 presents the results of sensitivity analysis for
premature mortality costs. The greatest impact on the
Fig. 3 Comparison between mean suicide-related LEYLL and SEYLL and mean all-cause death-related LEYLL and SEYLL in the Polish
population
Table 2 Sensitivity analyses for SEYLL according to different assumptions for the reference life tables















104,875 18.9 5.6 13,103 16.2 0.7 117,978 18.54 3.06
West Level-26 not age-
weighted and discounted
186,709 33.6 10.0 25,093 30.1 1.3 211,802 33.3 5
GBD 2010 206,152 37.1 11.1 25,610 31.6 1.3 231,762 36.4 6
GBD 2015 222,002 40 11.9 27,808 34 1.4 249,810 39.25 6.5
WHO GHE (base case
analysis)
247,928 45 13.3 31,497 39 1.6 279,425 43.9 7
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estimates of suicide-related premature mortality costs had
the value of the discount rate. With a 0% discount rate the
total cost was 117% higher in both sexes and in males, and
107% higher in females. An assumption of fixed wage
resulted in a 31% lower cost in both sexes and males, and a
30% lower cost in females. Extending the retirement age to
68 for both sexes resulted in an increase of costs by 66% in
females, by 15% in males and by 18% in both sexes
combined. Varying parameters that characterized the labor
market (unemployment rate, economic activity) had a
greater impact on costs in the female population than on
costs in the male population.
Discussion
Our findings provide quantitative evidence of the health-
related and economic impact of suicide. In absolute and
relative terms, suicide represents a significant loss to the
Polish economy, which accentuates the importance of
investing in effective prevention actions. A national sui-
cide prevention program was developed in 2012 and
suggested focusing on establishing an efficient collabora-
tion between emergency services, school staff, clergymen
and specialist medical units [23]. A comprehensive
training program for primary care physicians,
schoolteachers and social workers to recognize affective
disorders, suicidal thoughts and behavior is hoped to play
a major role in preventing the expected growth in suicide-
related mortality rates [23]. It is worth mentioning that the
efficacy of the first national preventive programs imple-
mented in the USA and some European countries in the
90s and their efficacy has been proven by a notable de-
crease of reported suicides (30–50% during a period of
5–15 years). Since 1953, when the Samaritans Organisa-
tion set in motion a 24-h suicide helpline, Great Britain
has noted a systematic decrease in the number of reported
suicides, making it one of Europe’s countries with the
lowest suicide rate [23].
Our study revealed substantial sex-specific differences
in both LEYLL and SEYLL due to suicide and in prema-
ture suicide-related mortality cost. Primarily, this is a
consequence of a substantially higher rate of fatal suicide
attempts among men. Except for China, where more
females than males die due to suicide [24], this is a ubiq-
uitous tendency. On average, the global male to female
suicide-related death ratio is 3.5:1. In Poland it amounts to
a distressing 7:1. Substantial sex-specific differences in
costs of premature mortality reflected sex- and age-related
variations in labor force participation and earnings. The use
of labor market data to derive costs results in the fact that
premature male deaths are ‘‘weighted’’ more heavily than
those of women. This is because, on average, men have
higher labor force participation rates than women and are
paid more.
The fact that suicide accounted for 3% of all-cause
mortality-related LEYLL and SEYLL and 10% af the total
premature mortality cost in Poland would not be expected a
priori based on the number of deaths from this cause (2%
of all deaths). The analysis and interpretation of death
registry using years of lost life and premature mortality
costs provide objective evidence for public health policy-
makers to inform and guide the setting of local public
health priorities. Moreover, mean years of lost life and
premature mortality cost per death provide an insight to the
burden of suicide and the effect it has on an individual,
rather than on the population as a whole, and bring atten-
tion to the importance of preventing premature, suicide-
related deaths.
In our study we have applied a long-established and
widely used methodology for high quality population-
based data in a consistent and transparent fashion. What
makes our study unique is that we have estimated both the
health-related and economic burden of suicide, included
LEYLL and SEYLL in the health-related estimations of the
burden of suicide and performed an extensive sensitivity
analysis to determine how different values of key param-
eters impact the base case estimates. To our knowledge,
such a detailed analysis has never been presented on a
national level before. In the recently published studies on
the burden of external-cause mortality in the Lodz province
[25], and premature mortality in Poland [10], years of life
lost were counted and analyzed by the method described in
GBD 1990 [20]. In these studies a mortality standard norm
(West Level-26) had a life expectancy of 80 years at birth
for males and 82.5 years for females, SEYLL was com-
puted with a 3% discount rate and age-weighting. Because
there have been substantial revisions to the methods of
calculating SEYLL, these estimates fail to meet the new
methodological requirements and may be comparable only
with one of the scenarios presented in the sensitivity
analysis.
Studies of the burden of suicide from other countries
[26–29] have used a different approach as well—they have
calculated the potential years of lost life (PYLL). This
methodology, recommended by the Organisation for Eco-
nomic Co-operation and Development (OECD), uses life
limits, e.g., 75 years [27] or 65 years [29], and does not
take into account the years lost due to deaths which occur
above this age limit.
In our study, we have calculated both LEYLL and
SEYLL. It is difficult to indicate which measure may be
more useful for decision makers in estimating the health-
related burden of suicide. On the one hand, calculating the
years of lost life using country-specific life tables reflects a
country-specific disease burden and incorporates strategies
Burden of suicide in Poland in 2012: how could it be measured and how big is it?
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used in cost-effectiveness analysis. On the other hand, the
projected life expectancy is influenced by pre-
ventable deaths which currently occur in a given popula-
tion. The standard reference life table is intended to
represent the potential maximum life span of an individual
in good health at a given age. Calculating SEYLL may
overestimate the years of lost life compared to LEYLL.
Nonetheless, SEYLL has several advantages: (1) the pro-
jected life expectancy represents the maximum life span of
an individual, and (2) it allows comparisons against the
same standard. Taking into consideration that country-
specific information is of higher importance for local
public health policymakers, LEYLL calculations, which
are based on country-specific mortality and country-
specific expected survival, seem to be more useful than
SEYLL. Moreover, this approach is in line with method-
ological recommendations for health outcome evaluation in
the cost-effectiveness analyses [15]. In this context SEYLL
can only serve as an additional measure useful for inter-
national comparative studies and global health estimates of
the burden of diseases, provided that the methods of cal-
culation comply with the working standards and require-
ments currently in force. Presently, GBD 2015
methodology proposed by IHME represents the up-to-date
strategy [2].
In our study the base case estimations of LEYLL were
calculated with discounting at 3.5%, as is recommended for
health outcome evaluation by the Polish HTA guidelines
[15]. In our opinion the evaluation of the burden of mor-
tality due to a given condition should follow these rec-
ommendations in order to avoid using parallel, oftentimes
inconsistent methods and to avoid decision-making para-
doxes when future costs of health interventions are dis-
counted. Critics of discounting argue that there is no
intrinsic reason to value a year of health as less important
simply because it is in the future. This argument might be
accurate if lost of life years had been defined as quantifying
loss of health rather than the social value of loss of heath.
LEYLL aims to quantify the social value of the loss of
health and in our opinion for this reason it should be dis-
counted, especially when is used to inform and guide the
setting of local public health priorities. Age-weighting
gives less weight to years of healthy life lost at young and
older ages [29]. The standard age-weighting formula is:
Cxe-bx, where x is the concerned age, and C and b are
constants commonly set to 0.1658 and 0.04. Age-weighting
is based on the theory of human capital, according to which
years lived as a young adult are valued higher than years
spent as a young child or older adult, because these are the
years of peak productivity. As mentioned above, estimating
LEYLL quantifies the social value of loss of health, while
society’s interest in productivity is better reflected by
estimating the loss of productive life years and costs of
premature mortality. Given the lack of consensus on social
weighting, we recommend calculating LEYLL under dif-
ferent scenarios, at least: ‘‘no discounting, no age-weight-
ing’’, ‘‘discounting at 3 or 3.5%, no age-weighting’’, and
‘‘discounting and age-weighting’’.
The cost of premature mortality was calculated by
multiplying the relevant number of lost work years with a
wage rate estimate. It has been argued that actual produc-
tivity costs may be strongly influenced by compensation
mechanisms adjustments [30]. However, evidence on such
mechanisms is scarce and, despite a number of studies, a
consensus on the methods used to produce productivity
cost estimates has not been reached [31]. Such a lack of
agreement is a likely reason for ignoring productivity costs
in the economic evaluation of the burden of a disease or
event.
Limitations of the study
We are well aware of the limitations of the present study.
The reliability of the analysis of Polish population mor-
tality due to suicide depends on the correct classification of
the primary cause of death. Our study is based on the data
from the register of deaths, run by the Central Statistical
Office. Death by suicide was defined as ‘‘intentional self-
harm’’ according to the ICD-10 categories X60–X84. This
is defined in a way that includes all suicide deaths, but has
somewhat wider logical scope. The accuracy of suicide
rates in the official reports may be influenced by wrong
classification of the cause of death.
Conclusions
Our study contributes to understanding of the burden of
suicide in Poland. Our results strongly indicate that within
the public health care sector, suicide prevention is an issue
to which priority should be given. It can be stated that each
of the demonstrated methods is valuable for the evaluation
of the impact of suicide on a given population: LEYLL
quantifies the social value of health loss, SEYLL quantifies
the health loss, and premature mortality costs reflect the
loss of productivity due to deaths. LEYLL and premature
mortality costs estimated according to national guidelines
have the most significant potential to be used by local
public health policymakers.
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